[{"id":"15f8ee23-e9b8-46d8-ad10-74d1a3c7150e","acronym":"","url":"https://clinicaltrials.gov/study/NCT06707961","created_at":"2025-02-26T11:42:45.150Z","updated_at":"2025-02-26T11:42:45.150Z","phase":"","brief_title":"Prognostic Study of Via Dynamic Change of PCA3 mRNA in Drainage Fluid After Radical Prostatectomy","source_id_and_acronym":"NCT06707961","lead_sponsor":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","biomarkers":" PCA3","pipe":"","alterations":" ","tags":["PCA3"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 100","initiation":"Initiation: 12/01/2024","start_date":" 12/01/2024","primary_txt":" Primary completion: 12/01/2025","primary_completion_date":" 12/01/2025","study_txt":" Completion: 12/01/2025","study_completion_date":" 12/01/2025","last_update_posted":"2024-11-27"},{"id":"6f495b84-e66c-4014-bcbc-7265a6df59c0","acronym":"","url":"https://clinicaltrials.gov/study/NCT04097002","created_at":"2021-07-05T17:25:16.739Z","updated_at":"2024-07-02T16:35:30.916Z","phase":"Phase 1/2","brief_title":"First in Man Clinical Study to Evaluate Safety and Tolerability of an Oncolytic Adenovirus in Prostate Cancer Patients.","source_id_and_acronym":"NCT04097002","lead_sponsor":"Orca Therapeutics B.V.","biomarkers":" PCA3","pipe":"","alterations":" ","tags":["PCA3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ORCA-010"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 24","initiation":"Initiation: 11/12/2019","start_date":" 11/12/2019","primary_txt":" Primary completion: 10/01/2024","primary_completion_date":" 10/01/2024","study_txt":" Completion: 12/01/2024","study_completion_date":" 12/01/2024","last_update_posted":"2023-10-31"},{"id":"4659e6a5-34e4-4dcf-af23-604fd8fe1047","acronym":"","url":"https://clinicaltrials.gov/study/NCT01632930","created_at":"2021-01-18T07:01:01.283Z","updated_at":"2024-07-02T16:36:17.676Z","phase":"","brief_title":"Medical Economics of Urinary PCA3 Test for Prostate Cancer Diagnosis","source_id_and_acronym":"NCT01632930","lead_sponsor":"Hospices Civils de Lyon","biomarkers":" PCA3","pipe":"","alterations":" ","tags":["PCA3"],"overall_status":"Completed","enrollment":" Enrollment 962","initiation":"Initiation: 07/02/2012","start_date":" 07/02/2012","primary_txt":" Primary completion: 04/26/2021","primary_completion_date":" 04/26/2021","study_txt":" Completion: 04/26/2021","study_completion_date":" 04/26/2021","last_update_posted":"2022-02-03"},{"id":"1778d39e-a30a-4e07-a5b7-62c504e7ce74","acronym":"","url":"https://clinicaltrials.gov/study/NCT04699344","created_at":"2021-01-19T20:50:09.087Z","updated_at":"2024-07-02T16:36:36.461Z","phase":"","brief_title":"A Prospective, Single-centre，Single-blinded Study of PROUD for Prostate Carcinoma Diagnosis","source_id_and_acronym":"NCT04699344","lead_sponsor":"Qilu Hospital of Shandong University","biomarkers":" PCA3","pipe":"","alterations":" ","tags":["PCA3"],"overall_status":"Recruiting","enrollment":" Enrollment 500","initiation":"Initiation: 01/25/2021","start_date":" 01/25/2021","primary_txt":" Primary completion: 01/31/2023","primary_completion_date":" 01/31/2023","study_txt":" Completion: 06/30/2023","study_completion_date":" 06/30/2023","last_update_posted":"2021-01-07"},{"id":"dd64d9c4-426f-4ce1-b12b-2d7745386bae","acronym":"","url":"https://clinicaltrials.gov/study/NCT00774436","created_at":"2021-01-18T02:55:34.837Z","updated_at":"2024-07-02T16:36:57.621Z","phase":"Phase 2","brief_title":"Study of Focal Cryoablation in Low-Risk Prostate Cancer","source_id_and_acronym":"NCT00774436","lead_sponsor":"Memorial Sloan Kettering Cancer Center","biomarkers":" PCA3","pipe":"","alterations":" ","tags":["PCA3"],"overall_status":"Completed","enrollment":" Enrollment 12","initiation":"Initiation: 10/14/2008","start_date":" 10/14/2008","primary_txt":" Primary completion: 07/23/2019","primary_completion_date":" 07/23/2019","study_txt":" Completion: 07/23/2019","study_completion_date":" 07/23/2019","last_update_posted":"2019-07-29"},{"id":"0bc8b313-5200-4c6e-90af-8e807a306558","acronym":"Triptocare","url":"https://clinicaltrials.gov/study/NCT01020448","created_at":"2021-01-18T04:00:08.624Z","updated_at":"2024-07-02T16:37:03.377Z","phase":"Phase 3","brief_title":"Effect of Triptorelin (Decapeptyl®) 22.5 mg on Two Biomarkers in Patients With Advanced Prostate Cancer","source_id_and_acronym":"NCT01020448 - Triptocare","lead_sponsor":"Ipsen","biomarkers":" ERG • TMPRSS2 • PCA3","pipe":"","alterations":" ","tags":["ERG • TMPRSS2 • PCA3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e triptorelin"],"overall_status":"Completed","enrollment":" Enrollment 339","initiation":"Initiation: 11/01/2009","start_date":" 11/01/2009","primary_txt":" Primary completion: 11/01/2011","primary_completion_date":" 11/01/2011","study_txt":" Completion: 06/01/2013","study_completion_date":" 06/01/2013","last_update_posted":"2019-01-30"},{"id":"0db1ef08-338b-411d-883c-503f4cc60632","acronym":"","url":"https://clinicaltrials.gov/study/NCT01296672","created_at":"2021-01-18T05:16:13.004Z","updated_at":"2024-07-02T16:37:17.285Z","phase":"Phase 4","brief_title":"3 Month Finasteride Challenge Test Can Significantly Improve the Performance of Screening for Prostate Cancer","source_id_and_acronym":"NCT01296672","lead_sponsor":"The University of Texas Health Science Center at San Antonio","biomarkers":" PCA3","pipe":"","alterations":" ","tags":["PCA3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e finasteride"],"overall_status":"Completed","enrollment":" Enrollment 383","initiation":"Initiation: 02/01/2011","start_date":" 02/01/2011","primary_txt":" Primary completion: 11/01/2016","primary_completion_date":" 11/01/2016","study_txt":" Completion: 01/01/2017","study_completion_date":" 01/01/2017","last_update_posted":"2017-10-06"},{"id":"5b72e4a9-3187-452b-ab83-2d1ec11d9c5f","acronym":"","url":"https://clinicaltrials.gov/study/NCT00375765","created_at":"2021-01-18T01:18:16.019Z","updated_at":"2024-07-02T16:37:26.391Z","phase":"Phase 4","brief_title":"Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer","source_id_and_acronym":"NCT00375765","lead_sponsor":"GlaxoSmithKline","biomarkers":" KLK3 • PCA3","pipe":"","alterations":" ","tags":["KLK3 • PCA3"],"overall_status":"Completed","enrollment":" Enrollment 40","initiation":"Initiation: 04/01/2005","start_date":" 04/01/2005","primary_txt":" Primary completion: 07/01/2007","primary_completion_date":" 07/01/2007","study_txt":" Completion: 07/01/2007","study_completion_date":" 07/01/2007","last_update_posted":"2017-01-19"}]